Publications

• Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A single cell RNA-seq analysis.
  Cancer Lett Volume: 625 Page(s): 217809
  08/10/2025 Authors: Nagaraju GP; Saddala MS; Sarvesh S; Bandi DSR; Khaliq AM; Masood A; Akce M; El-Rayes BF
• Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma.
  
  06/27/2025 Authors: Lee MS; Chao J; Mulcahy MF; Kasi PM; Alistar AT; Mukherjee S; Akce M; Moore DT; McRee AJ; Somasundaram A
• BPI25-016: Real-World Outcomes of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Insights From a Single Center in the Deep South.
  J Natl Compr Canc Netw Volume: 23
  03/28/2025 Authors: Mudd TW; Abby FA; Outlaw D; Akce M; El-Rayes B; Malla M; Hussaini QS; Gupta G
• ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma.
  Mol Cancer Volume: 24 Page(s): 76
  03/13/2025 Authors: Bandi DSR; Nagaraju GP; Sarvesh S; Carstens JL; Foote JB; Graff EC; Fang Y-HD; Keeton AB; Chen X; Valiyaveettil J
• Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine.
  Cell Rep Med Volume: 6 Page(s): 101881
  01/21/2025 Authors: Nagaraju GP; Saddala MS; Foote JB; Khaliq AM; Masood A; Golivi Y; Bandi DSR; Sarvesh S; Reddy SP; Switchenko J
• Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.
  J Hepatol Volume: 82 Page(s): 107 - 119
  01/01/2025 Authors: Rezaee-Zavareh MS; Yeo YH; Wang T; Guo Z; Tabrizian P; Ward SC; Barakat F; Hassanein TI; Dave S; Ajmera V
• Triplet regimen with camrelizumab plus apatinib in combination with hepatic artery infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma?
  Chin Clin Oncol Volume: 13 Page(s): 80
  10/01/2024 Authors: Gupta G; Patel R; Akce M; Chauhan A
• Association between frailty and overall survival among older adults with hepatocellular carcinoma.
  J Geriatr Oncol Volume: 15 Page(s): 102045
  09/01/2024 Authors: Ozluk AA; Williams GR; Dai C; Goldberg J; Malla M; Pywell C; Siwakoti K; Outlaw DA; Gupta G; El-Rayes B
• Management of Older Adults With Colorectal Cancer: The Role of Geriatric Assessment.
  Clin Colorectal Cancer Volume: 22 Page(s): 390 - 401
  12/01/2023 Authors: Ozluk AA; Outlaw D; Akce M; Fowler ME; Hess DL; Giri S; Williams GR
• Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.
  Curr Oncol Volume: 30 Page(s): 10100 - 10110
  11/25/2023 Authors: Villalobos A; Dabbous HH; Little O; Gbolahan OB; Akce M; Lilly MA; Bercu Z; Kokabi N
• Advances in Immunotherapy for Hepatocellular Carcinoma (HCC).
  Curr Oncol Volume: 30 Page(s): 9789 - 9812
  11/07/2023 Authors: Bicer F; Kure C; Ozluk AA; El-Rayes BF; Akce M
• Implementation of the Web-Enabled Cancer & Aging Resilience Evaluation (WeCARE) in an outpatient oncology setting.
  J Geriatr Oncol Volume: 14 Page(s): 101644
  11/01/2023 Authors: Harmon C; Fowler M; Giri S; Tucker A; Al-Obaidi M; Rocque G; Zubkoff L; Rogers LQ; Wildes TM; Pergolotti M
• NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
  Volume: 30 Page(s): 6558 - 6566
  10/01/2023 Authors: Maithel SK; Keilson JM; Cao HST; Rupji M; Mahipal A; Lin BS; Javle MM; Cleary SP; Akce M; Switchenko JM
• Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer.
  J Immunother Cancer Volume: 11
  10/01/2023 Authors: Akce M; Farran B; Switchenko JM; Rupji M; Kang S; Khalil L; Ruggieri-Joyce A; Olson B; Shaib WL; Wu C
• ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
  Ann Surg Oncol Volume: 30 Page(s): 6569 - 6570
  10/01/2023 Authors: Maithel SK; Keilson JM; Cao HST; Rupji M; Mahipal A; Lin BS; Javle MM; Cleary SP; Akce M; Switchenko JM
• Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies-Results from the CARE registry.
  Cancer Med Volume: 12 Page(s): 19102 - 19111
  09/01/2023 Authors: Clausing D; Fowler ME; Harmon C; Tucker A; Outlaw D; Akce M; El-Rayes B; Giri S; Williams GR
• Use of Metformin and Survival in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide Cancer Registry.
  Cardiovasc Intervent Radiol Volume: 46 Page(s): 870 - 879
  07/01/2023 Authors: Mukherjee K; Elsayed M; Choksi E; Loya MF; Duszak R; Akce M; Majdalany BS; Bercu ZL; Cristescu M; Kokabi N
• Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
  Lancet Volume: 401 Page(s): 1853 - 1865
  06/03/2023 Authors: Kelley RK; Ueno M; Yoo C; Finn RS; Furuse J; Ren Z; Yau T; Klmpen H-J; Chan SL; Ozaka M
• Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy.
  Oncogene Volume: 42 Page(s): 1051 - 1057
  03/01/2023 Authors: Akce M; El-Rayes BF; Wajapeyee N
• Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway).
  Front Oncol Volume: 13 Page(s): 860711
  01/01/2023 Authors: Jiao X-D; Qin B-D; Wang Z; Liu K; Wu Y; Ling Y; Qin W-X; Wang M-M; Yuan L-Y; Barreto SG
• Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma.
  Pancreas Volume: 52 Page(s): e75 - e84
  01/01/2023 Authors: Khalil L; Huang Z; Zakka K; Jiang R; Penley M; Alese OB; Shaib WL; Wu C; Behera M; Reid MD
• Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study.
  J Gastrointest Oncol Volume: 13 Page(s): 2306 - 2321
  10/01/2022 Authors: Atallah RP; Zhang Y; Zakka K; Jiang R; Huang Z; Shaib WL; Diab M; Akce M; Wu C; El-Rayes BF
• Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
  Oncologist Volume: 27 Page(s): 740 - 750
  09/02/2022 Authors: Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
• Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers.
  Cancers (Basel) Volume: 14
  03/29/2022 Authors: Kang S; El-Rayes BF; Akce M
• Neoadjuvant treatment of pancreatic carcinosarcoma: a case report and review of literature.
  Chin Clin Oncol Volume: 11 Page(s): 8
  02/01/2022 Authors: Lalonde CS; Wang L; Quigley B; Patel P; Maithel SK; El-Rayes BF; Akce M
• Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
  Oncology Volume: 100 Page(s): 131 - 139
  01/01/2022 Authors: Allaw MB; Switchenko JM; Khalil L; Wu C; Alese OB; Akce M; Draper A; Jones AT; El-Rayes B; Shaib W
• Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology.
  Front Oncol Volume: 12 Page(s): 821903
  01/01/2022 Authors: Kang SM; Khalil L; El-Rayes BF; Akce M
• Frontline therapy for advanced hepatocellular carcinoma: an update.
  Therap Adv Gastroenterol Volume: 15 Page(s): 17562848221086126
  01/01/2022 Authors: Akce M; El-Rayes BF; Bekaii-Saab TS
• Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report.
  Oncol Res Treat Volume: 45 Page(s): 430 - 437
  01/01/2022 Authors: Kang S; Magliocca J; Sellers M; Roccaro G; Zheng W; Pectasides M; Draper A; Guadagno J; El-Rayes B; Akce M
• Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study.
  Cancer Volume: 127 Page(s): 4585 - 4593
  12/15/2021 Authors: Harding JJ; Yang T-S; Chen Y-Y; Feng Y-H; Yen C-J; Ho C-L; Huang W-T; El Dika I; Akce M; Tan B
• Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.
  Cardiovasc Intervent Radiol Volume: 44 Page(s): 1937 - 1944
  12/01/2021 Authors: Elsayed M; Wagstaff W; Behbahani K; Villalobos A; Bercu Z; Majdalany BS; Akce M; Schuster DM; Mao H; Kokabi N
• CORRELATIVE ANALYSIS OF BLOOD AND BIOPSY SAMPLES FROM A CLINICAL TRIAL OF HSP90 INHIBITION IN COMBINATION WITH PEMBROLIZUMAB REVEALS INCREASED INTRATUMORAL MYELOID CELL ACCUMULATION AFTER TREATMENT
  Volume: 9 Page(s): A434 - A434
  11/01/2021 Authors: Herting C; Zhang Y; Doxie D; Ware M; Alese O; Wu C; Akce M; Zaidi M; Ruggieri A; Dhodapkar M
• Role of Resection of the Primary in Metastatic Well-Differentiated Neuroendocrine Tumors.
  Pancreas Volume: 50 Page(s): 1382 - 1391
  11/01/2021 Authors: Shaib WL; Zakka K; Penley M; Jiang R; Akce M; Wu C; Maithel SK; Sarmiento JM; Kooby D; Behera M
• Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.
  Cancer Chemother Pharmacol Volume: 88 Page(s): 825 - 836
  11/01/2021 Authors: Akce M; El-Khoueiry A; Piha-Paul SA; Bacque E; Pan P; Zhang Z-Y; Ewesuedo R; Gupta D; Tang Y; Milton A
• Negative enrichment of circulating tumor cells from unmanipulated whole blood with a 3D printed device.
  Sci Rep Volume: 11 Page(s): 20583
  10/18/2021 Authors: Chu C-H; Liu R; Ozkaya-Ahmadov T; Swain BE; Boya M; El-Rayes B; Akce M; Bilen MA; Kucuk O; Sarioglu AF
• A phase I trial of trifluridine/tipiracil in combination with nanoliposomal irinotecan in advanced GI cancers
  Volume: 32 Page(s): S200 - S200
  07/03/2021 Authors: Alese O; Shaib W; Akce M; Diab M; Issa-Boube M; Ekundayo F; Wu C; El-Rayes B
• Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review.
  Clin Colorectal Cancer Volume: 20 Page(s): 153 - 160
  06/01/2021 Authors: Bryson E; Sakach E; Patel U; Watson M; Hall K; Draper A; Davis C; Goyal S; Alese O; Akce M
• Survival Outcomes of Acinar Cell Pancreatic Cancer: A National Cancer Database Analysis.
  Pancreas Volume: 50 Page(s): 529 - 536
  04/01/2021 Authors: Shaib WL; Zakka K; Huang W; Chen Z; Alese OB; Wu C; Akce M; El-Rayes BF
• Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?
  Surg Oncol Volume: 36 Page(s): 120 - 129
  03/01/2021 Authors: Zakka K; Williamson S; Jiang R; Reid MD; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF; Akce M
• Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes.
  J Surg Oncol Volume: 123 Page(s): 596 - 605
  02/01/2021 Authors: Alese OB; Zakka K; Huo X; Jiang R; Shaib WL; Akce M; Behera M; Sullivan P; Wu C; El-Rayes BF
• Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
  Am J Clin Oncol Volume: 44 Page(s): 74 - 81
  02/01/2021 Authors: Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT
• Hepatocellular carcinoma: current state and future horizons.
  Chin Clin Oncol Volume: 10 Page(s): 1
  02/01/2021 Authors: Akce M; Maithel SK
• Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma.
  Can J Gastroenterol Hepatol Volume: 2021 Page(s): 9926704
  01/01/2021 Authors: Villalobos A; Wagstaff W; Guo M; Zhang J; Bercu Z; Whitmore MJ; Cristescu MM; Majdalany BS; Wedd J; Akce M
• Impact of high-risk features for stage II adenocarcinoma of the appendix.
  Volume: 27 Page(s): 100329
  01/01/2021 Authors: Akce M; Zakka K; Penley M; Jiang R; Khalil L; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
• Predictive and Prognostic Effects of Primary Tumor Size on Colorectal Cancer Survival.
  Front Oncol Volume: 11 Page(s): 728076
  01/01/2021 Authors: Alese OB; Zhou W; Jiang R; Zakka K; Huang Z; Okoli C; Shaib WL; Akce M; Diab M; Wu C
• High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer.
  Front Oncol Volume: 11 Page(s): 755113
  01/01/2021 Authors: Mohamed A; Jiang R; Philip PA; Diab M; Behera M; Wu C; Alese O; Shaib WL; Gaines TM; Balch GG
• Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status.
  Volume: 11 Page(s): 592351
  01/01/2021 Authors: Akce M; Zakka K; Jiang R; Williamson S; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
• INVESTIGATING THE CLINICAL SAFETY, EFFICACY, AND IMMUNE MODULATION OF COMBINED XL888 AND PEMBROLIZUMAB IN METASTATIC GASTROINTESTINAL MALIGNANCIES
  Volume: 8 Page(s): A202 - A203
  11/01/2020 Authors: Herting C; Zhang Y; Doxie D; Farren M; Ware M; Alese O; Wu C; Shaib W; Akce M; Zaidi M
• Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
  Cancer Volume: 126 Page(s): 4136 - 4147
  09/15/2020 Authors: Shaib WL; Zakka KM; Jiang R; Yan M; Alese OB; Akce M; Wu C; Behera M; El-Rayes BF
• Provider Recommendations for Phase I Clinical Trials Within a Shared Decision-Making Model in Phase I Cancer Clinical Trial Discussions.
  JCO Oncol Pract Volume: 16 Page(s): e859 - e867
  09/01/2020 Authors: Hianik RS; Campbell GP; Abernethy E; Lewis C; Wu CS; Akce M; Dixon MD; Shaib WL; Pentz RD
• Radiation as a Single-Modality Treatment in Localized Pancreatic Cancer.
  Pancreas Volume: 49 Page(s): 822 - 829
  07/01/2020 Authors: Shaib WL; Zakka K; Shahin AA; Yared F; Switchenko JM; Wu C; Akce M; Alese OB; Patel PR; Mcdonald M
• A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors.
  Clin Cancer Res Volume: 26 Page(s): 2497 - 2505
  06/01/2020 Authors: Owonikoko TK; Harvey RD; Carthon B; Chen Z; Lewis C; Collins H; Zhang C; Lawson DH; Alese OB; Bilen MA
• Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment.
  Volume: 38
  05/20/2020 Authors: Akce M; El-Khoueiry AB; Piha-Paul SA; Bacque E; Pan P; Zhang Z-Y; Ewesuedo R; Gupta D; Milton A; Judson P
• Adjuvant concurrent chemoradiotherapy in extrahepatic cholangiocarcinoma.
  Volume: 38
  05/20/2020 Authors: Shaib WL; Zakka KM; Tian F; Chen Z; Patel PR; Lin JY; Wu C; Akce M; Alese OB; El-Rayes BF
• Blood-based next-generation sequencing analysis of neuroendocrine neoplasms.
  Oncotarget Volume: 11 Page(s): 1749 - 1757
  05/12/2020 Authors: Zakka K; Nagy R; Drusbosky L; Akce M; Wu C; Alese OB; El-Rayes BF; Kasi PM; Mody K; Starr J
• High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
  Oncologist Volume: 25 Page(s): e877
  05/01/2020 Authors: Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
• Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers.
  Oncologist Volume: 25 Page(s): 414 - 421
  05/01/2020 Authors: Shaib WL; Zakka K; Staley C; Roberts A; Akce M; Wu C; Alese OB; El-Rayes BF
• In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy.
  J Geriatr Oncol Volume: 11 Page(s): 660 - 667
  05/01/2020 Authors: Shaib WL; Zakka K; Hoodbhoy FN; Belalcazar A; Kim S; Cardona K; Russell MC; Maithel SK; Sarmiento JM; Wu C
• Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
  Oncologist Volume: 25 Page(s): e528 - e535
  03/01/2020 Authors: Bilen MA; Martini DJ; Liu Y; Shabto JM; Brown JT; Williams M; Khan AI; Speak A; Lewis C; Collins H
• Young Adults With Pancreatic Cancer: National Trends in Treatment and Outcomes.
  Pancreas Volume: 49 Page(s): 341 - 354
  03/01/2020 Authors: Alese OB; Jiang R; Shaib W; Wu C; Akce M; Gaines T; Ni L; Behera M; El-Rayes BF
• The impact of inflammatory biomarkers, BMI, and sarcopenia on survival in advanced hepatocellular carcinoma treated with immunotherapy
  Volume: 38
  02/01/2020 Authors: Akce M; Liu Y; Zakka KM; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd J; Sellers MT
• Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts)
  Volume: 38
  02/01/2020 Authors: Sahin IH; Goyal S; Pumpalova YS; Sonbol MB; Das S; Haraldsdottir S; Chen Z; Akce M; Alese OB; Shaib WL
• Is adjuvant chemotherapy beneficial for stage II-III goblet cell tumors of the appendix?
  Volume: 38
  02/01/2020 Authors: Zakka KM; Williamson S; Jiang R; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF; Akce M
• Clinicopathological features and survival outcomes of rare histologic variants of gallbladder cancer.
  J Surg Oncol Volume: 121 Page(s): 294 - 302
  02/01/2020 Authors: Akce M; Zakka K; Penley M; Jiang R; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
• Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
  Cancer Volume: 126 Page(s): 575 - 582
  02/01/2020 Authors: Martini DJ; Kline MR; Liu Y; Shabto JM; Williams MA; Khan AI; Lewis C; Collins H; Akce M; Kissick HT
• Nonbacterial Thrombotic Endocarditis and Widespread Skin Necrosis in Newly Diagnosed Lung Adenocarcinoma.
  Case Rep Oncol Volume: 13 Page(s): 239 - 244
  01/01/2020 Authors: Zakka K; Zakka P; Davarpanah A; Koshkelashvili N; Bilen MA; Owonikoko T; El-Rayes B; Akce M
• Diagnosis and Staging of Pancreatic Cancer
  Page(s): 158 - 168
  01/01/2020 Authors: Mulki R; Mekaroonkamol P; Lopez-Aguiar AG; Lesinski GB; Kooby DA; Akce M; Maithel SK; Willingham FF
• Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
  Oncologist
  12/05/2019 Authors: Bilen MA; Martini DJ; Liu Y; Shabto JM; Brown JT; Williams M; Khan AI; Speak A; Lewis C; Collins H
• Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
  Invest New Drugs Volume: 37 Page(s): 1198 - 1206
  12/01/2019 Authors: Martini DJ; Liu Y; Shabto JM; Lewis C; Kline MR; Collins H; Akce M; Kissick HT; Carthon BC; Shaib WL
• Analysis of racial disparities in the treatment and outcomes of colorectal cancer in young adults.
  Cancer Epidemiol Volume: 63 Page(s): 101618
  12/01/2019 Authors: Alese OB; Jiang R; Zakka KM; Wu C; Shaib W; Akce M; Behera M; El-Rayes BF
• Clinical Outcomes of Small Bowel Adenocarcinoma.
  Volume: 18 Page(s): 257 - 268
  12/01/2019 Authors: Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
• Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms.
  Br J Cancer Volume: 121 Page(s): 809 - 818
  11/01/2019 Authors: Sahin IH; Akce M; Alese O; Shaib W; Lesinski GB; El-Rayes B; Wu C
• Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
  BMC Cancer Volume: 19 Page(s): 857
  08/29/2019 Authors: Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL
• Induction Therapy in Localized Pancreatic Cancer.
  Pancreas Volume: 48 Page(s): 913 - 919
  08/01/2019 Authors: Shaib WL; Sayegh L; Zhang C; Belalcazar A; Ip A; Alese OB; Akce M; Wu C; Qu Y; Maithel SK
• High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
  Oncologist Volume: 24 Page(s): 911 - 920
  07/01/2019 Authors: Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
• Heat shock protein 90 inhibitors alter pancreatic stellate cell cytokine production and enhances the efficacy of immune checkpoint blockade in pancreatic cancer
  Volume: 79
  07/01/2019 Authors: Zaidi M; Zhang Y; Ware MB; Farren MR; Komar H; Olson B; Nagaraju GP; Akce M; Alese O; Maithel S
• Perioperative therapy in patients with metastatic colorectal cancer.
  Volume: 37
  05/20/2019 Authors: Alese OB; Zakka KM; Huo X; Jiang R; Shaib WL; Wu C; Akce M; Sullivan PS; Behera M; El-Rayes BF
• Blood-based next-generation sequencing analysis of neuroendocrine tumors.
  Volume: 37
  05/20/2019 Authors: Shaib WL; Roberts A; Zakka KM; Akce M; Wu C; Alese OB; El-Rayes BF; Kasi PM; Starr JS
• Nonsurgical Management of Rectal Cancer.
  J Oncol Pract Volume: 15 Page(s): 123 - 131
  03/01/2019 Authors: Akce M; El-Rayes BF
• Clinical outcomes of hepatocellular carcinoma variants compared to hepatocellular carcinoma.
  Volume: 37
  02/01/2019 Authors: Zakka KM; Jiang R; Alese OB; Shaib WL; Wu C; Wedd J; Sellers MT; Behera M; El-Rayes BF; Akce M
• Genomic alterations in appendiceal carcinoma using circulating DNA.
  Volume: 37
  02/01/2019 Authors: Shaib WL; Roberts A; Akce M; Wu C; Alese OB; El-Rayes BF
• Impact of genomic alterations (GAs) on outcomes and their distribution by age groups in metastatic colorectal cancer (mCRC) patients (pts)
  Volume: 37
  02/01/2019 Authors: Sahin IH; Chen WH; Chen Z; Akce M; Alese OB; Shaib WL; El-Rayes BF; Wu C
• Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis.
  J Gastrointest Oncol Volume: 10 Page(s): 85 - 94
  02/01/2019 Authors: Akce M; Jiang R; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
• Sequential immunotherapy and association with clinical outcomes in advanced-stage cancer patients
  Volume: 7
  02/01/2019 Authors: Bilen M; Martini D; Liu Y; Lewis C; Collins H; Shabto J; Akce M; Kissick H; Carthon B; Shaib W
• Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma.
  J Hepatocell Carcinoma Volume: 6 Page(s): 119 - 129
  01/01/2019 Authors: Zakka K; Jiang R; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Behera M; El-Rayes BF; Akce M
• Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer.
  Cancer Volume: 125 Page(s): 57 - 67
  01/01/2019 Authors: Shaib WL; Narayan AS; Switchenko JM; Kane SR; Wu C; Akce M; Alese OB; Patel PR; Maithel SK; Sarmiento JM
• The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
  Cancer Volume: 125 Page(s): 127 - 134
  01/01/2019 Authors: Bilen MA; Martini DJ; Liu Y; Lewis C; Collins HH; Shabto JM; Akce M; Kissick HT; Carthon BC; Shaib WL
• Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO).
  Ann Oncol Volume: 29 Suppl 8 Page(s): viii433
  10/01/2018 Authors: Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins HH; Akce M; Kissick H; Carthon BC; Shaib WL
• Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO).
  Volume: 29 Suppl 8 Page(s): viii42
  10/01/2018 Authors: Bilen MA; Martini DJ; Shabto JM; Liu Y; Khan AI; Williams MA; Lewis C; Collins HH; Kissick H; Carthon BC
• CA209-9DX: phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation.
  Volume: 29 Suppl 8 Page(s): viii267 - viii268
  10/01/2018 Authors: Jimenez Exposito MJ; Akce M; Montero Alvarez JL; Assenat E; Balart LA; Baron AD; Decaens T; Heurgue-Berlot A; Martin AO; Paik SW
• Blood based biomarkers and association with clinical outcome (CO) in advanced stage patients (pts) treated with immunotherapy (IO)
  Volume: 78
  07/01/2018 Authors: Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Pillai R
• Impact of adjuvant chemotherapy in higher risk stage II colon cancer with a deficient mismatch repair (dMMR)/ microsatellite instability-high (MSI-H) profile.
  Volume: 36
  05/20/2018 Authors: Mohamed AMR; Jiang R; Philip PA; Diab M; Behera M; Wu C; El-Rayes BF; Akce M
• Retrospective study of the safety of administering pegfilgrastim on the same day of 5-Fluorouracil pump disconnect.
  Volume: 36
  05/20/2018 Authors: Patel N; Wu C; Draper A; LaFollette JA; Brutcher E; El-Rayes BF; Alese OB; Shaib WL; Akce M; Chen Z
• Incidence, treatment and survival outcomes of small bowel adenocarcinomas: A National Cancer Database (NCDB) analysis.
  Volume: 36
  05/20/2018 Authors: Akce M; Jiang R; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
• A phase I/II study of trifluridine/tipiracil (TAS-102) in combination with nanoliposomal irinotecan (NAL-IRI) in advanced GI cancers.
  Volume: 36
  05/20/2018 Authors: Alese OB; Shaib WL; Akce M; Wu C; El-Rayes BF
• Early change in blood-based biomarkers and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)
  Volume: 36
  05/20/2018 Authors: Martini DJ; Liu Y; Lewis CM; Shabto JM; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Pillai RN
• Adjuvant treatment for resected sub-centimeter T1 pancreatic cancer.
  Volume: 36
  05/20/2018 Authors: Shaib WL; Naranyan AS; Switchenko JM; Akce M; Sarmiento J; Maithel S; Kooby DA; Patel PR; Cardona K; Alese OB
• Altering the cytokine profile in the pancreatic cancer microenvironment with heat shock protein-90 inhibitors to enhance immunotherapy.
  Volume: 200
  05/01/2018 Authors: Lesinski GB; Zhang Y; Farren MR; Komar H; Ware B; Olson B; Zaidi M; Nagaraju GP; Akce M; Alese OB
• Resection of pancreatic cancer following induction chemotherapy.
  Volume: 36
  02/01/2018 Authors: Shaib WL; Sayegh L; Alese O; Maithel S; Cardona K; Sarmiento J; Belalcazar A; Ip A; Qu Y; Akce M
• Epidemiology and treatment of high-grade gastrointestinal neuroendocrine tumors (HG-GI-NETs)
  Volume: 36
  02/01/2018 Authors: Alese OB; Jiang R; Shaib WL; Wu CS-Y; Akce M; Behera M; El-Rayes BF
• Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies.
  Volume: 36
  02/01/2018 Authors: Akce M; Alese OB; Shaib WL; Wu CS-Y; Lesinski GB; El-Rayes BF
• The Potential of CAR T Cell Therapy in Pancreatic Cancer.
  Front Immunol Volume: 9 Page(s): 2166
  01/01/2018 Authors: Akce M; Zaidi MY; Waller EK; El-Rayes BF; Lesinski GB
• The effect of treatment delay on survival in patients with hepatocellular cancer.
  Volume: 35
  05/20/2017 Authors: Akce M; Sansgiry S; Temple SL; Davila J; Sada Y
• Immune analysis of fibrolamellar hepatocellular carcinoma
  Volume: 35
  02/01/2017 Authors: Akce M; Vence LM; Blando JM; Sharma P; Hassan M; Kaseb AO
• Trends in multimodality therapy for gastric cancer post-MAGIC.
  Volume: 35
  02/01/2017 Authors: Sada Y; Smaglo BG; Cao HST; Akce M; Mok H; Musher BL; Massarweh NN
• Pathologic nodal response in gastric cancer: Do all patients need adjuvant therapy?
  Volume: 35
  02/01/2017 Authors: Smaglo BG; Sada Y; Hop STC; Akce M; Mok H; Musher BL; Massarweh NN
• Screening for Cancer Genetic Syndromes With a Simple Risk-Assessment Tool in a Community-Based Open-Access Colonoscopy Practice.
  Am J Gastroenterol Volume: 111 Page(s): 589 - 593
  05/01/2016 Authors: Gunaratnam NT; Akce M; Al Natour R; Bartley AN; Fioritto AF; Hanson K; Ladabaum U
• Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma.
  Case Rep Hematol Volume: 2016 Page(s): 3598547
  01/01/2016 Authors: Akce M; Chang E; Haeri M; Perez M; Finch CJ; Udden MM; Mims MP
• Peritoneal tuberculosis mimicking peritoneal carcinomatosis.
  Case Rep Med Volume: 2014 Page(s): 436568
  01/01/2014 Authors: Akce M; Bonner S; Liu E; Daniel R
• A multifactorial intervention for hospital opioid management.
  J Opioid Manag Volume: 10 Page(s): 337 - 344
  01/01/2014 Authors: Akce M; Suneja A; Genord C; Singal B; Hopper JA
• Automated Utilization of Colorectal Cancer Risk Assessment Tool Prior to Open Access Colonoscopy Improves Detection of Those At Risk for Lynch Syndrome
  Volume: 144 Page(s): S393 - S393
  05/01/2013 Authors: Akce M; Bogi SR; Ladabaum U; Fioritto A; Hanson K; Bartley AN; Gunaratnam NT
• Multiple gastric metastases from ovarian carcinoma diagnosed by endoscopic ultrasound with fine needle aspiration.
  Case Rep Gastrointest Med Volume: 2012 Page(s): 610527
  01/01/2012 Authors: Akce M; Bihlmeyer S; Catanzaro A